Equities Analysts Set Expectations for PAHC Q4 Earnings

Phibro Animal Health Co. (NASDAQ:PAHC) – Equities researchers at Zacks Research lifted their Q4 2025 earnings per share estimates for shares of Phibro Animal Health in a note issued to investors on Wednesday, February 19th. Zacks Research analyst R. Department now expects that the company will post earnings per share of $0.50 for the quarter, up from their previous forecast of $0.43. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q2 2026 earnings at $0.53 EPS, Q4 2026 earnings at $0.59 EPS, FY2026 earnings at $1.91 EPS, Q2 2027 earnings at $0.55 EPS and FY2027 earnings at $2.17 EPS.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%.

PAHC has been the topic of a number of other reports. StockNews.com lowered Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 6th. Barclays lifted their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a research report on Monday, February 10th. Finally, Morgan Stanley lifted their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. Two analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $21.00.

Phibro Animal Health Price Performance

Shares of PAHC stock opened at $22.97 on Friday. The firm has a market cap of $930.29 million, a P/E ratio of 47.85, a P/E/G ratio of 0.47 and a beta of 0.52. Phibro Animal Health has a fifty-two week low of $11.90 and a fifty-two week high of $26.55. The business’s 50 day moving average price is $22.21 and its 200-day moving average price is $22.07. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Mackenzie Financial Corp purchased a new position in shares of Phibro Animal Health in the 4th quarter valued at approximately $478,000. Public Employees Retirement System of Ohio purchased a new position in Phibro Animal Health during the fourth quarter valued at $323,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Phibro Animal Health by 37.1% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 62,566 shares of the company’s stock valued at $1,314,000 after buying an additional 16,917 shares during the last quarter. Virtus Fund Advisers LLC purchased a new position in Phibro Animal Health during the fourth quarter valued at $69,000. Finally, Virtus Investment Advisers Inc. raised its stake in Phibro Animal Health by 103.4% during the fourth quarter. Virtus Investment Advisers Inc. now owns 49,504 shares of the company’s stock valued at $1,040,000 after buying an additional 25,160 shares during the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.09%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health’s payout ratio is presently 100.00%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.